4.6 Review

Acetylsalicylic Acid and Mood Disorders: A Systematic Review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Psychiatry

Association of Bipolar Disorder With Major Adverse Cardiovascular Events: A Population-Based Historical Cohort Study

Moein Foroughi et al.

Summary: This study found that patients with bipolar disorder (BD) have a higher risk of major adverse cardiac events (MACEs), even after adjusting for established cardiovascular disease risk factors, substance use disorders, and major depressive disorder.

PSYCHOSOMATIC MEDICINE (2022)

Review Neurosciences

Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders

Ellen Doney et al.

Summary: Regulation of emotions involves not only the brain but also peripheral systems, and the prevalence of stress and mood disorders is on the rise in modern societies. Many individuals have poor responses to current treatments, underscoring the need for further research into emotion-related biology for innovative therapies. Studies on inflammation-related mechanisms in mood regulation and stress responses using animal models highlight potential translational value and novel therapeutic approaches.

EUROPEAN JOURNAL OF NEUROSCIENCE (2022)

Article Medicine, General & Internal

Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis

Amanda M. Lambert et al.

Summary: This systematic review examined the relationship between severe mental illness (SMI) and cardiovascular disease (CVD) and found a strong association between SMI and increased incidence and mortality from CVD, particularly in the 1990s and among younger individuals.

PLOS MEDICINE (2022)

Article Pharmacology & Pharmacy

Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats

Rachel Shvartsur et al.

Summary: Mounting evidence suggests that immune-system dysfunction and inflammation play a role in the pathophysiology and treatment of mood disorders. This study found that chronic combined treatment attenuated LPS-induced hypothermia and reduced cytokine levels, suggesting a potential approach for treating inflammation-related mental illness. The treatment also showed antidepressant-like effects.

PHARMACEUTICS (2022)

Review Medicine, General & Internal

Effect of celecoxib on improving depression: A systematic review and meta-analysis

Zhi Wang et al.

Summary: This study conducted a meta-analysis and found that celecoxib could be effective in improving depression. However, heterogeneity and publication bias were observed in the analysis. Sensitivity analysis and risk of bias assessment confirmed the reliability of the meta-analysis results.

WORLD JOURNAL OF CLINICAL CASES (2022)

Article Mathematical & Computational Biology

Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments

Luke A. McGuinness et al.

Summary: Despite the availability of numerous software options for evidence synthesis, there is currently no universal tool for generating figures to display and explore risk-of-bias assessments. However, tools such as the R programming environment and Shiny have made it easy to create new tools for producing evidence syntheses. The new tool robvis facilitates the rapid production of publication-quality risk-of-bias assessment figures and is available as an R package and web app.

RESEARCH SYNTHESIS METHODS (2021)

Review Oncology

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers

Peter C. Elwood et al.

Summary: Research suggests that cancer patients who take aspirin may experience a significant reduction in both cancer-specific mortality and all-cause mortality by about 20%. This benefit seems to be applicable across a range of cancer types, indicating that aspirin could be a valuable adjuvant treatment for cancer patients.

ECANCERMEDICALSCIENCE (2021)

Article Immunology

Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability

Marco Solmi et al.

Summary: The study aimed to compare inflammatory mediators in bipolar disorder (BD) with healthy controls, finding that CRP and TNF-alpha may be state markers as they were only elevated during mood episodes, while IL-6 appeared to be a trait marker for BD. The variability of specific inflammatory mediators in specific disease active states suggests that some BD subjects may exhibit elevated inflammation during manic or depressive episodes.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Review Biochemistry & Molecular Biology

AMPK activators for the prevention and treatment of neurodegenerative diseases

Natalie R. Neumann et al.

Summary: As the global population ages rapidly, the burden of neurodegenerative diseases is expected to increase. This article reviews the role of AMPK activation in neuroprotection and the potential of AMPK activators in managing dementia and cognitive impairment. The authors suggest that AMPK activators could be considered for the treatment and prevention of neurodegenerative diseases, outlining areas for future research.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)

Article Pharmacology & Pharmacy

Inflammation in Bipolar Disorder (BD): Identification of new therapeutic targets

Ana Catarina Pereira et al.

Summary: Bipolar disorder is a chronic and cyclic mental disorder characterized by unusual mood swings and has deleterious impact on society and economy. Inflammation plays a key role in the pathophysiology of BD, with evidence showing altered levels of cytokines, activated microglial cells, and the involvement of inflammation in BD pointing towards inflammation as a novel and attractive therapeutic target for BD.

PHARMACOLOGICAL RESEARCH (2021)

Article Health Care Sciences & Services

The prevalence of bipolar disorder in autoimmune disease: a systematic review and meta-analysis

Mengyi Chen et al.

Summary: The meta-analysis showed a significant increase in the incidence of bipolar disorder in patients with autoimmune diseases, and a high comorbidity rate of autoimmune diseases and bipolar disorder was confirmed. More basic research is needed to verify the special significance of immune mechanisms in bipolar disorder.

ANNALS OF PALLIATIVE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial

Michael Berk et al.

Summary: The study found that aspirin did not have any long-term benefits on late-life depression in a sample of older adults over a 5-year period. On the contrary, it showed a negative impact on the course of depression in those with pre-existing depressive symptoms.

MOLECULAR PSYCHIATRY (2021)

Article Pharmacology & Pharmacy

Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats

Rachel Shvartsur et al.

Summary: Chronic low-dose aspirin can mitigate the typical renal side effects of standard-dose lithium and enhance the beneficial behavioral effects of low-dose lithium therapy without aggravating its toxicity.

PHARMACEUTICS (2021)

Review Medicine, General & Internal

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

Matthew J. Page et al.

Summary: The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess trustworthiness. PRISMA 2020 aims to improve the transparency and completeness of systematic review reporting, in hopes of guiding more accurate and transparent reporting.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Clinical Neurology

Neuroinflammation in Major Depressive Disorder: A Review of PET Imaging Studies Examining the 18-kDa Translocator Protein

Davide Gritti et al.

Summary: A review of in vivo PET imaging studies found upregulation of TSPO in specific regions of the brain in patients with MDD. Treatment with antidepressants and cognitive behavioral therapy may lead to reduced brain inflammation. Additionally, anti-inflammatory treatment with cyclooxygenase inhibitors showed positive effects.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Review Neurosciences

Is cyclooxygenase-1 involved in neuroinflammation?

Nafiseh Ghazanfari et al.

Summary: The review summarizes the evidence supporting the involvement of COX-1 in neuroinflammation, highlighting that COX-1 can be upregulated by inflammatory stimuli leading to increased production of prostaglandin E2. Inhibition of COX-1 was shown to suppress the induction of inflammatory mediators. Imaging studies in animal models confirmed COX-1 overexpression during neuroinflammation, but not in patients with Alzheimer's disease.

JOURNAL OF NEUROSCIENCE RESEARCH (2021)

Review Biochemistry & Molecular Biology

Progress in PET Imaging of Neuroinflammation Targeting COX-2 Enzyme

Jaya Prabhakaran et al.

Summary: Neuroinflammation and COX-2 upregulation play important roles in degenerative brain diseases, with PET imaging being a valuable tool for assessing COX-2 induction in vivo. Promising radioligands like [11CTMI], [11C]MC1, and [18F]MTP have demonstrated BBB permeability and binding to COX-2 in the brain, showing potential for clinical translation.

MOLECULES (2021)

Review Oncology

Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials

Lijuan Wang et al.

Summary: This study indicates that regular low-dose aspirin use can reduce the risk of colorectal, gastric, breast, and prostate cancer, but not lung cancer. High-frequency aspirin use may increase the risk of lung cancer, while high-dose use may increase the risk of prostate cancer. Further research is needed to confirm these findings and determine the minimum effective dose for cancer prevention.

FRONTIERS IN ONCOLOGY (2021)

Review Clinical Neurology

How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies

Kyu Man Han et al.

Summary: This narrative review explores how inflammation affects brain function and structure in depression, focusing on the role of microglial cells in producing pro-inflammatory cytokines. Recent MRI studies have shown associations between peripheral inflammatory markers and functional and structural neuroimaging markers in depression, shedding light on the neural circuit dysfunction in depression.

JOURNAL OF CLINICAL NEUROLOGY (2021)

Article Neurosciences

Upregulation of IL-1 Receptor Antagonist by Aspirin in Glial Cells via Peroxisome Proliferator-Activated Receptor-Alpha

Sudipta Chakrabarti et al.

Summary: Aspirin upregulates IL-1Ra in the brain by binding to PPAR alpha and stimulating its activity, therefore reducing inflammation in different neurological conditions.

JOURNAL OF ALZHEIMERS DISEASE REPORTS (2021)

Review Cell Biology

Inflammatory signaling mechanisms in bipolar disorder

Gregory H. Jones et al.

Summary: Bipolar disorder is a heterogeneous and multifactorial disease, where inflammation plays a significant role in affecting various systems. Understanding the role of inflammation in connecting these systems is crucial for identifying promising future targets for therapeutic development and screening.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Review Biochemistry & Molecular Biology

Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review

Vijayasree V. Giridharan et al.

MOLECULAR PSYCHIATRY (2020)

Article Spectroscopy

Multi spectroscopy and molecular modeling aspects related to drug interaction of aspirin and warfarin with pepsin; structural change and protease activity

Sajad Moradi et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)

Review Psychiatry

Prevalence and correlates of major depressive disorder: a systematic review

Luis Gutierrez-Rojas et al.

BRAZILIAN JOURNAL OF PSYCHIATRY (2020)

Review Public, Environmental & Occupational Health

Efficacy of Aspirin for Vasculogenic Erectile Dysfunction in Men: A Meta-Analysis of Randomized Control Trials

Muhammad Irfan et al.

AMERICAN JOURNAL OF MENS HEALTH (2020)

Article Psychiatry

New drug candidates for depression - a nationwide population-based study

L. V. Kessing et al.

ACTA PSYCHIATRICA SCANDINAVICA (2019)

Article Clinical Neurology

New drug candidates for bipolar disorder-A nation-wide population-based study

Lars V. Kessing et al.

BIPOLAR DISORDERS (2019)

Review Behavioral Sciences

Revisiting inflammation in bipolar disorder

Gabriel R. Fries et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Review Clinical Neurology

Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review

Chenghao Yang et al.

JOURNAL OF AFFECTIVE DISORDERS (2019)

Review Clinical Neurology

Animal models of major depression: drawbacks and challenges

Barbara Planchez et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

Review Neurosciences

Clinical Role of Aspirin in Mood Disorders: A Systematic Review

Qin Xiang Ng et al.

BRAIN SCIENCES (2019)

Article Geriatrics & Gerontology

Aspirin and incident depressive symptoms: A longitudinal cohort study over 8years

Nicola Veronese et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)

Review Neurosciences

Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder

Jairo Vinicius Pinto et al.

CURRENT NEUROPHARMACOLOGY (2018)

Review Clinical Neurology

Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials

Joshua D. Rosenblat et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Article Psychiatry

Inflammatory theory of depression

Piotr Galecki et al.

PSYCHIATRIA POLSKA (2018)

Review Medicine, General & Internal

Traditional Chinese medicine: herb-drug interactions with aspirin

Jia Wei Lim et al.

SINGAPORE MEDICAL JOURNAL (2018)

Article Endocrinology & Metabolism

Differential contribution of COX-1 and COX-2 derived prostanoids to cortical spreading depressionEvoked cerebral oligemia

Helaine Gariepy et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)

Review Clinical Neurology

Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems

Ana SayuriYamagata et al.

JOURNAL OF AFFECTIVE DISORDERS (2017)

Review Psychiatry

A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients

Pavani Sayana et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2017)

Review Hematology

The aspirin story - from willow to wonder drug

Michael J. R. Desborough et al.

BRITISH JOURNAL OF HAEMATOLOGY (2017)

Article Psychiatry

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies

C. A. Kohler et al.

ACTA PSYCHIATRICA SCANDINAVICA (2017)

Review Psychiatry

The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets

Bruna M. Ascoli et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2016)

Letter Clinical Neurology

Statin and Aspirin Use and the Risk of Mood Disorders among Men

Lana J. Williams et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)

Article Clinical Neurology

Long-term risk of myocardial infarction and stroke in bipolar I disorder: A population-based Cohort Study

Miguel L. Prieto et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

Review Clinical Neurology

Mortality and life expectancy in persons with severe unipolar depression

Thomas Munk Laursen et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

Review Pharmacology & Pharmacy

Aspirin, stroke and drug-drug interactions

Nicholas W. Russo et al.

VASCULAR PHARMACOLOGY (2016)

Review Geriatrics & Gerontology

Depression and Quality of Life in Older Persons: A Review

Heidi Sivertsen et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2015)

Article Clinical Neurology

Causes of decreased life expectancy over the life span in bipolar disorder

Lars Vedel Kessing et al.

JOURNAL OF AFFECTIVE DISORDERS (2015)

Review Psychiatry

Bipolar disorder prevalence: a systematic review and meta-analysis of the literature

Adauto S. Clemente et al.

REVISTA BRASILEIRA DE PSIQUIATRIA (2015)

Review Psychiatry

Lithium nephrotoxicity

Abed N. Azab et al.

INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2015)

Review Biochemistry & Molecular Biology

Lithium and the Other Mood Stabilizers Effective in Bipolar Disorder Target the Rat Brain Arachidonic Acid Cascade

Stanley I. Rapoport

ACS CHEMICAL NEUROSCIENCE (2014)

Article Immunology

Neuroinflammation in bipolar disorder - A [11C]-(R)-PK11195 positron emission tomography study

Bartholomeus C. M. (Benno) Haarman et al.

BRAIN BEHAVIOR AND IMMUNITY (2014)

Review Psychiatry

Is bipolar disorder an inflammatory condition? The relevance of microglial activation

Laura Stertz et al.

CURRENT OPINION IN PSYCHIATRY (2013)

Article Clinical Neurology

Prevalence of distress, comorbid conditions and well being in the general population

Joerg Wiltink et al.

JOURNAL OF AFFECTIVE DISORDERS (2011)

Article Multidisciplinary Sciences

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

Jennifer L. Warner-Schmidt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Neurosciences

A Meta-Analysis of Cytokines in Major Depression

Yekta Dowlati et al.

BIOLOGICAL PSYCHIATRY (2010)

Article Biochemistry & Molecular Biology

Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder

Pieter Stolk et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)

Article Pharmacology & Pharmacy

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

Julien Mendlewicz et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)

Article Pharmacology & Pharmacy

Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression

Nicoletta Brunello et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)

Article Biochemical Research Methods

Animal models for the study of antidepressant activity

C Gambarana et al.

BRAIN RESEARCH PROTOCOLS (2001)